Orchestra BioMed Inc.

NASDAQ: OBIO · Real-Time Price · USD
2.56
-0.10 (-3.76%)
At close: Aug 15, 2025, 3:59 PM
2.57
0.19%
After-hours: Aug 15, 2025, 07:58 PM EDT

Orchestra BioMed Revenue

Orchestra BioMed reported an annual revenue of $2.64M, reflecting a -4.42% growth. For the quarter ending June 30, 2025, Orchestra BioMed generated $836K in revenue.
Revenue (ttm)
2.64M
Revenue Growth
-4.42%
Price / Sales Ratio
55.83
Revenue / Employee
37.69K
Employees
70
Market Cap
138.39M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.